SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Anika Therapeutics, Inc. – ‘PREC14A’ on 3/27/23 re: Anika Therapeutics, Inc. – ‘EX-101.DEF’

On:  Monday, 3/27/23, at 8:48am ET   ·   Accession #:  1193125-23-79887   ·   File #:  1-14027

1 Reference:  By:  SEC – ‘UPLOAD’ on 4/4/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/23  Anika Therapeutics, Inc.          PREC14A               12:7.2M Anika Therapeutics, Inc.          Donnelley … Solutions/FA

Preliminary Proxy Statement – Contested Solicitation   —   Schedule 14A

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: PREC14A     Preliminary Proxy Statement - Contested             HTML   1.25M 
                Solicitation                                                     
 6: R1          Cover                                               HTML     16K 
 7: R2          Pay vs Performance Disclosure                       HTML    258K 
10: XML         IDEA XML File -- Filing Summary                      XML     20K 
 8: XML         XBRL Instance -- d480900dprec14a_htm                 XML    348K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX     16K 
 3: EX-101.DEF  XBRL Definitions -- anik-20221231_def                XML     20K 
 4: EX-101.LAB  XBRL Labels -- anik-20221231_lab                     XML     24K 
 5: EX-101.PRE  XBRL Presentations -- anik-20221231_pre              XML     18K 
 2: EX-101.SCH  XBRL Schema -- anik-20221231                         XSD     18K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks              101±   126K 
12: ZIP         XBRL Zipped Folder -- 0001193125-23-079887-xbrl      Zip   2.29M

‘EX-101.DEF’   —   XBRL Definitions — anik-20221231_def

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 27-March-2023 [03:50:10] {PM} -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly"/>
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"/>
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllIndividualsMember" xlink:label="AllIndividualsMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_BlanchardMember" xlink:label="BlanchardMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllIndividualsMember" xlink:to="BlanchardMember" order="100"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_DarlingMember" xlink:label="DarlingMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllIndividualsMember" xlink:to="DarlingMember" order="101"/>
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2022q4/ecd-2022q4.xsd#ecd_AllAdjToCompMember" xlink:label="AllAdjToCompMember"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_AdjustmentsRelatedToEquityAwardsMember" xlink:label="AdjustmentsRelatedToEquityAwardsMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="AdjustmentsRelatedToEquityAwardsMember" order="102"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_GrantFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="GrantFairValueOfEquityAwardsMadeDuringYearMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="GrantFairValueOfEquityAwardsMadeDuringYearMember" order="103"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_YearEndFairValueOfEquityAwardsMadeDuringYearMember" xlink:label="YearEndFairValueOfEquityAwardsMadeDuringYearMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearEndFairValueOfEquityAwardsMadeDuringYearMember" order="104"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" xlink:label="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember" order="105"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" xlink:label="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember" order="106"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember" xlink:label="FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember" order="107"/>
<loc xlink:type="locator" xlink:href="anik-20221231.xsd#anik_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember" xlink:label="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember"/>
<definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AllAdjToCompMember" xlink:to="FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember" order="108"/>
</definitionLink>
</linkbase>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/04/23  SEC                               UPLOAD8/04/23    2:43K  Anika Therapeutics, Inc.
↑Top
Filing Submission 0001193125-23-079887   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 6:04:22.1pm ET